30 minute infusion of isatuximab shows potential in newly diagnosed multiple myeloma
30 minute infusion of isatuximab shows potential in newly diagnosed multiple myeloma
CDK4/6 inhibitors and endocrine therapy in elderly female patients with advanced hormone receptor positive HER-2 negative BC
Perioperative chemotherapy is superior to neoadjuvant chemoradiation in oesophageal adenocarcinoma
MR-Linac on-line weekly adaptive radiotherapy shows positive results for high grade glioma
Geriatric interventions are beneficial in reducing treatment-related toxicity in older adults with cancer
Unlocking the potential of liquid biopsy applications in personalised care for older adults with cancer
One-year mortality in older adults with breast cancer: prediction using different geriatric tools
Daratumumab-based maintenance regimens show favourable responses in transplant-eligible NDMM
Optimising benefit-risk and minimising impact on quality of life with BCMA-targeting agents in an outpatient setting
Study shows the importance of including patient voices in treatment discussions for older cancer patients
Understanding the remaining unmet needs in a post ASCT NDMM setting
Approaches to risk stratification in high risk myeloma